Quantcast

CambridgeSoft Utilizes JNBridge’s Interop Technology to Protect Multinational Drug Company’s Intellectual Property

March 3, 2010

BOULDER, Colo., March 3 /PRNewswire/ — JNBridge, (www.jnbridge.com), the award-winning provider of Java and .NET Framework-based interoperability tools, enabled developers at CambridgeSoft Corporation (www.cambridgesoft.com) to easily integrate Java-based digital signature APIs into their .NET-based electronic lab notebook product. CambridgeSoft supplies discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and consulting services to the pharmaceutical, biotechnology, and chemical industries.

Using JNBridgePro, developers at CambridgeSoft now are easily able to integrate third-party Java-based digital signature technology into the .NET infrastructure of E-Notebook — CambridgeSoft’s electronic lab notebook software — to quickly meet business and compliance requirements of a major pharmaceutical customer.

“It takes an incredible amount of work to solve such a complex interoperability problem,” said Alfred Nehme, director of application development at CambridgeSoft. “JNBridgePro provided a level of Java and .NET integration that otherwise would have been very difficult and time-consuming to do ourselves.”

Protecting intellectual property (IP) and adhering to government regulations are crucial requirements for organizations engaged in biotechnology, drug discovery and chemical research. To comply with record keeping requirements in laboratory notes, CambridgeSoft implements digital signature and efficient archiving capabilities in its E-Notebook product. Using Public Key Infrastructure (PKI) technology, E-Notebook can embed digital signatures and timestamps, creating a reliable electronic record that cannot be falsified.

Recently a major multinational pharmaceutical customer wanted to use CambridgeSoft’s E-Notebook, but required a different Public Key Infrastructure (PKI) for digital signatures. The customer needed their chemists to sign experiments related to drug development using the same third-party, Java-based digital signature infrastructure that was already deployed in other parts of the company. To deliver this functionality, CambridgeSoft needed to integrate the required Java PKI API with E-Notebook, which is based on a .NET architecture. CambridgeSoft used JNBridgePro to simplify the interoperability between Java and .NET, allowing E-Notebook to call the Java APIs from .NET and thus fulfill their customer’s requirements.

CambridgeSoft project leaders now are easily able to embed the needed Java digital signature APIs rapidly into the E-Notebook application. JNBridgePro includes proxy generation plug-ins for Eclipse and Visual Studio IDEs, as well as an intuitive standalone GUI. Using the GUI, CambridgeSoft developers created proxies for the Java APIs that simplified access to the needed Java classes.

“JNBridgePro enables developers to mix and match technologies between Java and .NET,” said Wayne Citrin, CTO of JNBridge. “Customers appreciate the ability to retain their current investments while building applications that incorporate best-of-breed components from both platforms.”

For more information on JNBridge Pro or JNBridge JMS Adapters for .NET and BizTalk please visit: (www.jnbridge.com).

About JNBridge

JNBridge connects Java and .NET Framework-based components and applications together with tools and adapters that are fast, simple to use and remove the complexities of cross-platform interoperability. JNBridge is a privately-held company based in Boulder, Colorado. Founded in 2001, JNBridge has over 400 unique customers in 40 countries that use JNBridge’s award-winning solutions in a wide variety of applications in financial services, insurance, media, manufacturing and other industries. Please visit www.jnbridge.com for more information.


    Contact information:
    --------------------
    Christie Denniston
    Catapult PR-IR
    Office: 303-581-7760, ext. 13
    Cell: 303-827-5164
    cdenniston@catapultpr-ir.com

SOURCE JNBridge


Source: newswire



comments powered by Disqus